Search results
ASCO24: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena via Yahoo Finance· 6 hours agoThe therapy was evaluated as...NCT05599984). The study enrolled 49 patients, of which 22 had small...
FDA grants IND clearance for Adicet Bio’s renal cell carcinoma treatment trial
Clinical Trials Arena via Yahoo Finance· 9 hours ago“The FDA’s clearance of our IND application to evaluate ADI-270 in patients with...
Shannen Doherty is preparing to lose her hair for the third time ahead of chemo
TODAY via Yahoo News· 17 hours agoShannen Doherty's cancer, stage 4, has been progressing. She has shared health updates along the...
New treatment for advanced prostate cancer put on FDA fast track
WXYZ-TV Detroit· 20 hours agoBiontech has announced that their new antibody-drug conjugate candidate aimed at treating advanced...
Anixa advances ovarian cancer CAR-T therapy trial By Investing.com
Investing.com· 23 hours agoAnixa Biosciences, Inc. (NASDAQ: NASDAQ:ANIX), a biotechnology firm, announced today the treatment...
NGS: the road to personalising cancer care
Medical Device Network via Yahoo Finance· 5 days ago“This is a powerful new technology,” Baehner says. “Today it's reimbursed in colorectal cancer, but I think this is a technology that will be broadly...
GenFleet receives China NMPA approval for Phase I/II solid tumour trial
Clinical Trials Arena via Yahoo Finance· 5 days ago"GenFleet receives China NMPA approval for Phase I/II solid tumour trial" was originally created and...
New immunotherapy shows promise for advanced colorectal cancer in early trial
MedicalNewsToday via AOL· 5 days agoA combination of two monoclonal antibodies was effective in 61% of people with the most common form...
Groundbreaking cancer treatment may trigger more cancer – but here’s why you shouldn’t worry
The Conversation· 6 days agoIn the last few decades, scientists have finally learned to harness the immune system to successfully treat cancer. Car-T therapy, short for “chimeric antigen receptor T-cell ...
Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer
Zacks via Yahoo Finance· 24 hours agoBristol Myers (BMY) wins FDA approval for Krazati, in combination with Erbitux, as a targeted ...